Related Experiment Videos
Functional bovine immunoglobulins in Boophilus microplus hemolymph
I da S Vaz Júnior1, R H Martinez, A Oliveira
1Centro de Biotecnologia do Estado do Rio Grande do Sul, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brazil.
Veterinary Parasitology
|March 1, 1996
Summary
Bovine immunoglobulins pass into the hemolymph of the cattle tick (Boophilus microplus), retaining antibody activity. This finding is crucial for developing cattle vaccines to control tick-borne diseases.
Area of Science:
- Veterinary Entomology
- Immunology
- Parasitology
Background:
- Cattle ticks (Boophilus microplus) transmit diseases, impacting livestock health and productivity.
- Understanding immunoglobulin transfer from cattle to ticks is vital for effective disease control strategies.
- Vaccination of cattle is a key approach to combat tick infestations and associated diseases.
Purpose of the Study:
- To quantify bovine immunoglobulin passage into tick hemolymph during feeding.
- To determine the functional antibody activity of these immunoglobulins within the tick.
- To assess the implications for cattle vaccination strategies against tick-borne diseases.
Main Methods:
- Competitive ELISA was used to quantify bovine immunoglobulin levels in tick hemolymph.
- Western blot assay was employed to detect antibody activity against tick antigens.
- Ticks were fed on cattle immunized with purified tick egg antigens.
Main Results:
- Approximately 2% of bovine serum immunoglobulins were detected in the hemolymph of Boophilus microplus.
- Antibody activity against B. microplus antigens was confirmed in the hemolymph of ticks fed on immunized cattle.
- Functional antibodies remained detectable in engorged ticks for at least 48 hours post-feeding.
Conclusions:
- Bovine antibodies can be transferred to and maintained in the hemolymph of Boophilus microplus.
- The presence of functional antibodies in ticks supports the potential of anti-tick vaccines for disease transmission blocking.
- This research provides a basis for developing novel vaccination strategies targeting tick-host interactions.